We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 447

FTC and DOJ Update Antitrust Guidelines for the Licensing of Intellectual Property
  • McDermott Will & Emery
  • USA
  • January 18 2017

On January 13, 2017, the Federal Trade Commission (FTC) and the Antitrust Division of the US Department of Justice (DOJ) issued updated Antitrust


Merger control: gun jumping goes global
  • McDermott Will & Emery
  • European Union, USA
  • June 28 2010

Broadly defined, "gun jumping" refers to unlawful premerger coordination between the parties to an M&A transaction


Nexium Case Extends Actavis Ruling
  • McDermott Will & Emery
  • USA
  • January 3 2017

Addressing a pay-for-delay and pharmaceutical-settlement antitrust jury trial for the first time since the 2012 Supreme Court of the United States


President-Elect Trump Has Once-in-a-Century Opportunity to Substantially Revise the FTC’s Law Enforcement and Regulatory Agenda
  • McDermott Will & Emery
  • USA
  • January 6 2017

Bilal Sayyed, a McDermott partner and former official at the Federal Trade Commission, has prepared a thoughtful series of recommendations for


Massachusetts Court Weighs in on Product Hopping Allegations and Reverse Payment Standing
  • McDermott Will & Emery
  • USA
  • November 11 2016

Addressing a motion to dismiss a bevy of antitrust allegations, the US District Court for the District of Massachusetts held that a class of


How to (legally) keep competitors from poaching your key employees: antitrust law and non-poachingnon-solicitation agreements
  • McDermott Will & Emery
  • USA
  • August 16 2013

How can a company legally protect its valuable interests in key employees, when a competitor can just swoop in with a more attractive employment


Split decisions regarding class certification in provigil antitrust lawsuits
  • McDermott Will & Emery
  • USA
  • October 30 2015

In two antitrust class actions in the U.S. District Court for the Eastern District of Pennsylvania, the court denied class certification as to


Ninth Circuit weighs in on compulsory nature of antitrust claims and choice of law issues
  • McDermott Will & Emery
  • USA
  • September 28 2009

The U.S. Court of Appeals for the Ninth Circuit affirmed the lower court’s dismissal of antitrust claims, finding that the claims in issue were compulsory counterclaims that the defendant had failed to plead in response to a prior patent infringement lawsuit


Fiduciary Duties of Overlapping Directors
  • McDermott Will & Emery
  • USA
  • October 26 2016

A recent settlement involving Clayton Act enforcement highlighted antitrust concerns arising from situations in which directors and officers of one


Recent Enforcement Trends in Divestiture Packages
  • McDermott Will & Emery
  • USA
  • August 8 2016

The Federal Trade Commission (FTC) and US Department of Justice's (DOJ) Antitrust Division have been actively challenging mergers and acquisitions